earnings is the sole category represented across all 2 tracked stories. Of the tracked stories, 2 of 2 also mention Biofrontera Inc., the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Ameluz
earnings is the sole category represented across all 2 tracked stories. Of the tracked stories, 2 of 2 also mention Biofrontera Inc., the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. Their average consequence score of 5 runs below the beat's 6.4 for that window. Ameluz appears in 2 tracked Finance stories from March 19, 2026.
Stories tracked
2
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 105 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Ameluz. Shared-story counts are live from our verified record — not editorial picks.
Biofrontera and DarioHealth reported Q4 2025 results on March 19, 2026, highlighting a strategic shift from aggressive growth to sustainable profitability. While Biofrontera focuses on expanding its dermatology market share with Ameluz, DarioHealth is leveraging its B2B2C model to drive high-margin digital health revenue.
Armanino Foods and Biofrontera Inc. both reported record-breaking fourth-quarter and full-year 2025 financial results on March 19, 2026. These reports highlight strong execution in the specialty food and dermatological pharmaceutical sectors, respectively.
Ameluz is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.